drugset / Trial / NCT01169805

Prophylactic Effects of Ondansetron, Ramosetron, and Palonosetron on Patient-Controlled Analgesia Related Nausea and Vomiting After Urologic Laparoscopic Surgery

NCT01169805

Completed 105 enrolled Yonsei University
RandomizedParallel-groupDouble-blindPrevention

Summary

The aim of this prospective randomized controlled study was to compare the prophylactic effects of intravenous single dose of ondansetron, ramosetron, and palonosetron on PCA-related nausea and vomiting after urologic laparoscopic surgery.

Timeline

Start
2010-08
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ondansetron Other / unclassified 4 mg Intravenous
Subject Palonosetron Other / unclassified 0.075 mg Intravenous
Subject Ramosetron Small molecule 0.3 mg Intravenous